J. Taieb

R. Frydman, J. Thalabard, J. Taieb, 2001, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Rapid fetal fibronectin swab-test in preterm labor patients treated by betamimetics.

R. Frydman, Y. Ville, J. Taieb, 1997, European journal of obstetrics, gynecology, and reproductive biology.

High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status.

R. Fanchin, R. Frydman, J. Taieb, 2005, Human reproduction.

Follicular fluid concentration of leukaemia inhibitory factor is decreased among women with polycystic ovarian syndrome during assisted reproduction cycles.

J. Taieb, G. Chaouat, J. Taupin, 2001, Human reproduction.

FSH and its second messenger cAMP stimulate the transcription of human anti-Müllerian hormone in cultured granulosa cells.

R. Fanchin, R. Frydman, J. Taieb, 2011, Molecular endocrinology.

Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting 'poor responders' in in-vitro fertilization.

R. Fanchin, R. Frydman, J. Taieb, 1994, Human reproduction.

Down syndrome maternal serum markers in oocyte donation and other assisted reproductive technologies

A. Benachi, J. Taieb, M. Senat, 2017, Prenatal diagnosis.

Relationship between vitamin D status in the first trimester of pregnancy and gestational diabetes mellitus - A nested case-control study.

A. Benachi, C. Elie, N. Winer, 2020, Clinical nutrition.

Interferon-alpha-mediated prevention of in vitro apoptosis of chronic lymphocytic leukemia B cells: role of bcl-2 and c-myc.

M. Auffredou, A. Vazquez, J. Taieb, 1994, Clinical immunology and immunopathology.

Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.

R. Fanchin, J. Taieb, D. Dewailly, 2013, Human reproduction.

Anti-Müllerian hormone: clinical insights into a promising biomarker of ovarian follicular status.

D. H. Mendez Lozano, R. Fanchin, R. Frydman, 2006, Reproductive biomedicine online.

Use of the Architect-i2000 estradiol immunoassay during in vitro fertilization.

J. Taieb, R. Diop, C. Benattar, 2003, Clinical chemistry.

The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program.

R. Fanchin, R. Frydman, J. Taieb, 1994, Fertility and sterility.

Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13 weeks into pregnancy.

R. Frydman, M. Duyme, L. Salomon, 2003, American journal of obstetrics and gynecology.

Prevention of premature luteinizing hormone and progesterone rise with a gonadotropin‐releasing hormone antagonist, NaI‐Glu, in controlled ovarian hyperstimulation

R. Frydman, J. Taieb, D. de Ziegler, 1992, Fertility and sterility.

Enlightenment about the new Architect-i2000 estradiol (Abbott Laboratories) immunoassay during in vitro fertilization.

D. H. Mendez Lozano, J. Taieb, C. Poüs, 2007, Clinical biochemistry.

IL-4 counteracts anti-mu-induced human B cell proliferation: involvement of a cAMP-dependent inhibitory pathway.

M. Auffredou, G. Leca, A. Vazquez, 1991, European cytokine network.

Levels of follicular G-CSF and interleukin-15 appear as noninvasive biomarkers of subsequent successful birth in modified natural in vitro fertilization/intracytoplasmic sperm injection cycles.

R. Fanchin, R. Frydman, J. Taieb, 2011, Fertility and sterility.

Premature plasma progesterone and androgen elevation are not prevented by adrenal suppression in in vitro fertilization.

R. Fanchin, R. Frydman, J. Taieb, 1997, Fertility and sterility.

Delayed assessment of serum and whole blood estradiol, progesterone, follicle-stimulating hormone, and luteinizing hormone kept at room temperature or refrigerated.

R. Frydman, J. Taieb, F. Olivennes, 2000, Fertility and sterility.

Efficiency of Ultrasound and Biochemical Markers for Down’s Syndrome Risk Screening

R. Frydman, Y. Ville, J. Taieb, 1999, Fetal Diagnosis and Therapy.

Dynamics of serum anti-Müllerian hormone levels during the luteal phase of controlled ovarian hyperstimulation.

D. H. Mendez Lozano, R. Fanchin, R. Frydman, 2005, Human reproduction.

[Evidence of follicle responsiveness to FSH by antimüllerian hormone in ovulating women].

R. Fanchin, R. Frydman, J. Taieb, 2009, Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia.

Comparison of day 3 FSH serum values as determined by six different immunoassays.

R. Frydman, J. Taieb, C. Righini, 2002, Human reproduction.

Le dosage du 17β-estradiol sur un nouvel automate d'immunoanalyse: le Vitros ECi (Ortho-Clinical Diagnostics)

J. Taieb, A. Lindenbaum, V. Esteve, 1998 .

Vitamin D status during pregnancy and in cord blood in a large prospective French cohort.

A. Benachi, C. Elie, N. Winer, 2019, Clinical nutrition.

New automated antimüllerian hormone assays are more reliable than the manual assay in patients with reduced antral follicle count.

R. Fanchin, J. Taieb, J. Benhaim, 2016, Fertility and sterility.

Scheduled administration of a gonadotrophin-releasing hormone antagonist (Cetrorelix) on day 8 of in-vitro fertilization cycles: a pilot study.

R. Fanchin, R. Frydman, J. Taieb, 1995, Human reproduction.

Anti-Müllerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization.

N. Frydman, R. Fanchin, R. Frydman, 2007, The Journal of clinical endocrinology and metabolism.

Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation.

R. Fanchin, R. Frydman, J. Taieb, 1999, Human reproduction.